Iannacone Francesco P, Visconti Francesca, Zanoletti Elisabetta
Department of Neuroscience DNS, Otolaryngology Section, University of Padova, 35100 Padova, Italy.
Audiol Res. 2023 Feb 8;13(1):116-129. doi: 10.3390/audiolres13010012.
Since both surgery and more conservative treatments show long-term outcomes in patients with VS, the current challenge in its therapeutic strategy is to offer a cure with lower functional morbidity in terms of facial and hearing preservation or the possibility of hearing rehabilitation with a cochlear implant.
PubMed and Scopus databases were searched from 2017 to November 2022. Fifteen articles met our selection criteria: (1) patients with a diagnosis of VS, either sporadic or NF2-related; (2) simultaneous or sequential cochlear implantation; (3) specified audiological test results and follow-up timing.
Although the level of evidence for the presently included studies is low due to either the study design or the lack of treatment consensus, CI rehabilitation is a promising option, especially in small VS with compromised hearing and as a salvage option after a failed attempt at hearing preservation surgery.
由于手术治疗和更保守的治疗方法在听神经瘤患者中均显示出长期疗效,目前其治疗策略面临的挑战是在保留面部功能和听力或通过人工耳蜗进行听力康复的可能性方面,以较低的功能发病率实现治愈。
检索了2017年至2022年11月的PubMed和Scopus数据库。15篇文章符合我们的入选标准:(1)诊断为听神经瘤的患者,包括散发性或与神经纤维瘤病2型(NF2)相关的;(2)同期或分期人工耳蜗植入;(3)明确的听力学检查结果和随访时间。
尽管由于研究设计或缺乏治疗共识,目前纳入研究的证据水平较低,但人工耳蜗康复是一个有前景的选择,特别是对于听力受损的小型听神经瘤,以及在听力保留手术失败后的挽救性选择。